<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Bio Briefing - Bio Agents: Smallpox]]></title><link>http://www.upmc-biosecurity.org/</link><description><![CDATA[Biosecurity Briefing articles relating to smallpox biological agents.]]></description><copyright><![CDATA[Copyright 2010. University of Pittsburgh Medical Center. All rights reserved.]]></copyright><managingEditor><![CDATA[webmaster@umpc-biosecurity.org]]></managingEditor><webmaster><![CDATA[webmaster@umpc-biosecurity.org]]></webmaster><lastBuildDate>Mon, 04 Jan 2010 15:11:21 GMT</lastBuildDate><generator>SiteExecutive v4.1</generator><item><title><![CDATA[CDC Reports Vaccinia Infections among Laboratory Workers, Stresses Importance of Vaccination and Biosafety (04-25-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/smallpox/2008-04-25-cdcrptsinfectionlabwrkrs.html</link><description><![CDATA[Biosecurity Briefing: According to the CDC, state health departments reported a total of five cases of laboratory-acquired vaccinia infection to the CDC between 2005-2007. Vaccinia (VACV) is the live virus component of the smallpox vaccine.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/smallpox/2008-04-25-cdcrptsinfectionlabwrkrs.html</guid><pubDate>Mon, 28 Apr 2008 15:02:55 GMT</pubDate></item><item><title><![CDATA[Acambis Wins USG Contract for Smallpox Vaccine (04-25-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/smallpox/2008-04-25-acambisusgsmallpoxvac.html</link><description><![CDATA[Biosecurity Briefing: Reuters reported that British vaccine developer Acambis won a $425 million, 10-year contract to supply the U.S. govt with 9 million doses of the ACAM2000 smallpox vac. each year for delivery to the Strategic National Stockpile.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/smallpox/2008-04-25-acambisusgsmallpoxvac.html</guid><pubDate>Fri, 25 Apr 2008 21:51:43 GMT</pubDate></item><item><title><![CDATA[Study Shows Smallpox Vaccine Effective in Diluted Doses (02-16-2007)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2007-02-16-studysmallpxvaceffectivesmdose.html</link><description><![CDATA[Biosecurity Briefing: The March 15, 2007 edition of the Journal of Infectious Diseases published a study conducted to determine if diluted doses of smallpox vaccine offers effective protection from the disease.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2007-02-16-studysmallpxvaceffectivesmdose.html</guid><pubDate>Fri, 16 Feb 2007 19:57:00 GMT</pubDate></item><item><title><![CDATA[Progress on Development of 3rd Generation Smallpox Vaccines (03-03-2006)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2006-03-03-progressondevelof3rdgensmal.html</link><description><![CDATA[Biosecurity Briefing: Among the abstracts presented at the ASM Biodefense Research Meeting were several pertaining to the development of potentially safer smallpox vaccines]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2006-03-03-progressondevelof3rdgensmal.html</guid><pubDate>Wed, 31 Jan 2007 20:15:40 GMT</pubDate></item><item><title><![CDATA[Study Finds Greater Risks Associated with European Smallpox Vaccine (09-08-2006)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2006-09-08-risksassociatedeuropeanvacc.html</link><description><![CDATA[Biosecurity Briefing: On August 22, 2006, the journal Public Library of Science (PLoS) Medicine published a study indicating that the European smallpox vaccine may have higher morbidity and mortality to than the U.S. vaccine due to differences in strain.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2006-09-08-risksassociatedeuropeanvacc.html</guid><pubDate>Fri, 08 Sep 2006 17:22:00 GMT</pubDate></item><item><title><![CDATA[Recent Discoveries May Lead to New Smallpox Treatment and SARS Vaccine (08-11-2006)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2006-08-11-recentdiscovsmpxSARS.html</link><description><![CDATA[Biosecurity Briefing: In an August 4 news release, researchers at the University of Pennsylvania School of Medicine announced the discovery of a smallpox virus enzyme which may provide clues to the development of new drugs to target the virus.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2006-08-11-recentdiscovsmpxSARS.html</guid><pubDate>Fri, 11 Aug 2006 17:22:00 GMT</pubDate></item><item><title><![CDATA[HHS Amends Request for Proposal for Third Generation Smallpox Vaccine (07-28-2006)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2006-07-28-hhsamendsrfpfor3rdgensmpxvx.html</link><description><![CDATA[Biosecurity Briefing: On July 24, HHS issued an amendment to its request for proposal (RFP) for the acquisition of third generation smallpox vaccine based on modified vaccinia Ankara (MVA) for the Strategic National Stockpile (SNS).]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/smallpox/2006-07-28-hhsamendsrfpfor3rdgensmpxvx.html</guid><pubDate>Fri, 28 Jul 2006 20:18:00 GMT</pubDate></item></channel></rss>
